Aptevo Therapeutics Stock Target Price and Analyst Consensus
| APVO Stock | USD 0.78 0.07 8.24% |
The current analyst and expert consensus on Aptevo Therapeutics is Strong Buy, with only one strong buy opinion. The current projected Aptevo Therapeutics target price consensus is 8.38 with 2 analyst opinions. The most common way Aptevo Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Aptevo Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Aptevo Therapeutics. We encourage you to use your own analysis of Aptevo Therapeutics to validate this buy or sell advice. Aptevo Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Aptevo Therapeutics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Aptevo Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.
Lowest Forecast 7.63 | Highest Forecast 9.3 | Target Price 8.38 |
Aptevo |
It's important to approach Aptevo Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Aptevo Therapeutics price targets
Aptevo Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Aptevo Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Aptevo Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Aptevo Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Aptevo Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Aptevo Therapeutics is a key component of Aptevo Therapeutics valuation and have some predictive power on the future returns of a Aptevo Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptevo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | USD Crypto Fund Invested one share | |
Check out Macroaxis Advice on Aptevo Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Aptevo Stock analysis
When running Aptevo Therapeutics' price analysis, check to measure Aptevo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptevo Therapeutics is operating at the current time. Most of Aptevo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aptevo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptevo Therapeutics' price. Additionally, you may evaluate how the addition of Aptevo Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
The data published in Aptevo Therapeutics' official financial statements usually reflect Aptevo Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Aptevo Therapeutics. For example, before you start analyzing numbers published by Aptevo accountants, it's critical to develop an understanding of what Aptevo Therapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Aptevo Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aptevo Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Aptevo Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aptevo Therapeutics. Please utilize our Beneish M Score to check the likelihood of Aptevo Therapeutics' management manipulating its earnings.